Hidradenitis Suppurativa: Evaluation of Treatment Modalities and Patients’ Satisfaction
Transcription
Hidradenitis Suppurativa: Evaluation of Treatment Modalities and Patients’ Satisfaction
Egypt. J. Plast. Reconstr. Surg., Vol. 27, No. 2, July: 231-237, 2003 Hidradenitis Suppurativa: Evaluation of Treatment Modalities and Patients’ Satisfaction KHALED M. EL-RIFAIE, M.D.*; TAREK F. EL-WAKIL, M.D.**; AHMAD M. SOBHI, M.D.* and HISHAM EL-SAKET, M.D.* The Department of Surgery, Faculty of Medicine* and National Institute of Laser Enhanced Sciences**, Cairo University. ABSTRACT and socially handicapped and dressing dependent [3]. Unfortunately, the end point of the disease could be the malignant transformation in the form of squamous cell carcinoma as was reported in few cases of previous studies [4-5]. Hidradenitis suppurativa (H.S.) disease is a chronic suppurating disorder of an unknown aetiology. Its management must be individualized according to the affected regions and the extent of the disease with different success and recurrence rates. Twenty-one patients with H.S. disease at different regions and age groups of both sexes were studied. Five cases were presented as a recurrent disease. Excision and debridement were done for all the patients. Some defects were left for granulations and spontaneous healing while others were covered by either skin grafts or flaps. The reported results were summarized into short and long-term results. Short-term results include assessment of the operative time, patients’ ambulation, postoperative analgesics, hospitalization period and professional dependency for wound care. Long-term results include social, cosmetic results, patients’ satisfaction, as well as, the recurrence rate over a postoperative period of one year with a single reported recurrence at the axilla of a previously recurrent case. H.S. patients are of unique characteristics that suffered for a long time. Wide local excision could be attributed as the universal treatment modality per se or in conjunction with other lines for defect’s coverings with different success and recurrence rates. The management of H.S. disease must be individualized to the site and the extent of the disease. Initial conservative measures with antibiotics, local wound care and limited incision and drainage can alleviate the acute symptoms especially at early stages [3]. However, more radical surgery will likely be necessary in order to control advanced stages, as well as, to prevent recurrence. Options include deroofing and marsupialization, local excision, or more extensive operative excision with primary or secondary closure, skin grafting, or flap coverage of the defects. Wide excision will offer the most definitive therapy, with the trade-off being of a high morbidity [6]. Split-thickness skin grafts in the anal canal may contract and result into anal stenosis and should be avoided. Perianal H.S. is often best managed with local excision alone, with primary closure for small defects and either deroofing or healing by secondary intention for larger defects [7-8]. This could be achieved especially with the regression of the previously described diverting colostomy and central hyperalimentation [9-10] for avoidance of faecal contamination after the advancement at the well-planned preoperative and postoperative bowel regimens [7]. The same policy was suggested for the treatment of H.S. of the groin [11], while others suggested a new surgical treatment for chronic gluteal H.S. with the reused or recycled skin graft from the resected skin itself [2]. INTRODUCTION Hidradenitis suppurativa (H.S.) disease is a chronic socially debilitating disorder of unknown etiology. Physicians usually under-estimate the extent of the patient disability especially perineal and perianal H.S. [1]. At earlier stages of the disease, responding localized lesions are present. Quiescence is inconsistency achieved with the good personal hygiene and by avoidance of depilatories, shaving, irritating cloths and deodorants [2]. Later on, chronic disease developed when multiple abscesses, inflammatory induration, ulcerative sinus tracts and mal-odorous discharge were present. At this stage only, the patient seeks the surgical advice when the condition is miserable. The patient became physically 231 232 Vol. 27, No. 2 / Hidradenitis Suppurativa Moreover, there is a controversy about how to cover the defect after excision of axillary H.S. disease. Some authors recommended covering the defect by the use of fasciocutaneous flaps [1,12-14], while others recommended scapular island or parascapular flaps [14,15]. However, many authors reported better results of splitthickness grafting for the coverage than primary suturing, flaps, or even left for secondary intention [16,17] especially with the aid of negative pressure dressing [18]. Recently, carbon dioxide (CO2) laser (wavelength of 10600 nm) was introduced for the local excision of chronic H.S. disease [19-20] which could be optionally applied through a scannerassisted [21]. This new innovative modality for excision could facilitate the identification of coagulase-negative staphylococci, which are mostly present and cultured from the deeper planes of chronic H.S. disease [22]. Collectively, although a number of different reconstructive techniques have been described for the treatment of H.S. disease, none of them could be described as the treatment of choice and all of these treatment modalities can leave unsightly scars. This motivates us for the initiation of the present study to investigate the advantages and disadvantages of the different modalities for the treatment of H.S. at different locations with their implication for patients’ satisfaction. PATIENTS AND METHODS Twenty-one patients with H.S. disease involving the axilla, perineal, perianal, groin, gluteal and scrotal regions were studied. Five patients presented with recurrent H.S. There were two patients with recurrent H.S. disease at the axilla, while recurrent H.S. disease at gluteal, groin and perineal regions were present in one patient at each site. Moreover, two patients with axillary H.S. presented with bilateral lesions. All patients were treated from 1999-2001. They were reviewed in Table (1). There were 13 males (61.91%) and 8 females (38.09%). Their ages were ranged from 36-72 years with a mean of 57.48±10.51 years. Involved skin and apocrine tissue were excised to a clean, non-scarred area of subcutaneous tissue. In few selected cases, excision of the involved skin was done by the aid of CO2 laser (wavelength 10600 nm), DEKKA, Italy, at a power of 15W, pulsed at a pulse duration of 0.2 sec. The nearby fistulous tracts were deroofed to provide an adequate drainage and granulation tissue was excised and curetted. The average excised surface area was 320 cm2. After excision, wounds were too large for consideration of primary closure. There are different types for defect coverage, which are basically depended upon the site of the defect. In patients presented with groin H.S., skin coverage after excision was achieved by external oblique rotation fasciocutaneous in all the 5 cases (Fig. 1:a and b). In the case with gluteal H.S., coverage with split-thickness graft was done. In the ten cases with perineal and perianal H.S., the defects were left for secondary intention (Fig. 2). In five cases with axillary H.S., parascapular flaps were used at 5 sites and splitthickness grafts at 2 sites (Fig. 2: a, b and c). Broad-spectrum antibiotic coverage was generally provided with the induction of general anaesthesia to control the intraoperative bacteremia. Postoperative specific antibiotic coverage according to cultured organisms was provided. Operative wounds were dressed initially and changed the morning after surgery. Thereafter, dressings were changed four times daily. The patients were encouraged to ambulate as tolerated as early as possible. The patients were discharged when analgesic requirements were minimal and when a reliable outpatient wound care could be ensured. Patients were followed on an outpatient basis until healing was complete. They were evaluated on a weekly basis and then much less frequently, depending on their needs and desires for up to a year after surgery. Patients were interviewed according to a standardized questionnaire to assess the short and long-term results. The results can be evaluated as short and long-term results. The short-term results include; assessment of the operative time, patients’ ambulation, postoperative analgesics, duration of hospitalization and the hospital-dependency for wound care. However, the long-term results include; social results in the form of patients’ return to work, patients’ satisfaction and the final cosmetic results of the scar as well as the recurrence of the H.S. disease or any other complications if present. Recurrence may be either locoregional that appear at the surgical site, or de novo suppurating lesions that appear at sites more than 5 cm away from the surgical site. Egypt, J. Plast. Reconstr. Surg., July 2003 233 Fig. (3-A): A preoperative photograph of a case with axillary H.S. disease. Fig. (1-A): A preoperative photograph of a case with groin H.S. disease. Fig. (3-B): The operative defect after excision. Fig. (1-B): Postoperative photograph of external oblique fasciocutaneous flap. Fig. (3-C): Postoperative photograph of a healed split thickness skin graft. Fig. (2): A preoperative photograph of a case with perianal H.S. disease. 234 Vol. 27, No. 2 / Hidradenitis Suppurativa Table (1): Review of the patients’ data. Patient Age Sex 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 52 66 72 36 68 59 50 62 47 39 55 70 60 51 51 66 70 62 45 57 69 Female Male Male Male Female Male Female Female Male Female Male Male Female Male Male Male Male Female Male Female Male RESULTS The initial surgical intervention is usually in the form of a debridement. The operative time spent in most instances was less than one hour, while it was longer when flaps were designed to cover the wounds’ defects. The majority of the operative time was spent for careful debridement and curettage, as well as, for haemostasis that is why CO2 laser stripping could be of value. It was found that the patients’ ambulation from beds was achieved from the morning after surgery, which was initially with assistance. Two of our patients required no postoperative analgesics. Most patients reported a major reduction of the local discomfort as compared to the preoperative state. However, the condition is usually aggravated during and after dressings. By the 3rd-4th postoperative day, all patients had minimal analgesic requirements with satisfactory pain control. The period of hospitalization ranged from 2 days to 2 weeks. The prolonged hospital staying was due to complicated medical problems like controlling of diabetes mellitus or systemic hypertension. The longer hospitalizations were Disease distribution Groin Perineum Perineum and scrotum Axilla Groin (Recurrent) Perineum Groin Axilla Axillae (Bilateral, recurrent) Groin Gluteal (Recurrent) Perineum Perineum Perineum Axilla (Recurrent) Perineum (Recurrent) Groin Perineum Axillae (Bilateral) Perineum Perineum Healing time 3 months 5 months 6 months 4 months 4 months 5 months 5 months 3 months 6 months 5 months 4 months 5 months 5 months 3 months 4 months 6 months 5 months 4 months 3 months 3 months 4 months uniformly with older patients to allow closer wound observation especially for those with flaps and split-thickness grafts for covering and dressings especially for those cases who were left to cover by secondary intention until adequate and uncomplicated home-based care could be achieved. Regarding the wound care, a clean sterile technique, as well as, the use of minimal expenditures for gauze sponges were encouraged. The majority of patients were not hospital-dependant for regular dressing and only continue a smoothly home-based care. Only three patients required assistance for dressing care and were easily managed by spouse and/or family members. Complete healing required from 3 to 6 months, which depends on the extent of the initial disease and the debridement area. All the patients were followed postoperatively for 6-12 months to ensure, not only the complete cure of the disease, but also to assess the recurrence of an active disease. The duration of the healing was found ranging from 3 to 6 months (mean of 4.38±1.02 months). Follow-up examinations were completed with a questionnaire at Egypt, J. Plast. Reconstr. Surg., July 2003 the time of the hospital discharge or on the later recall to the outpatient clinics for good assessment of the patient’s satisfaction. There was only one patient reported unsatisfactory results as was denoted by a starting recurrent axillary H.S. disease at the margins of the area covered by a split-thickness graft. This was found to be recurrent for the second time, but only on one side. In this case, however, the reported disease was mild as compared to the original state of the disease. Recovery was achieved with minor excision of additional skin and apocrine glands and continued for dressings aiming to cover the defect by secondary intention. Seven patients had been unemployed due to the severity of their disease. Five of those patients were able to assume gainful employment about 3 months after their hospital discharge. Previously employed patients were generally returned to work about 3 weeks after hospital discharge. No patient reported inconvenience with the dressing care during the healing period when compared with his/her preoperative dressing requirements. The long-term results entail that all patients were satisfied about the final appearance of their wounds after complete healing. Two patients expressed concern for scar hypertrophy at the 12th postoperative month evaluation. Additionally, one patient expressed minor concern for apparent scar spreading where healing occurred, in part, through epithelization. No scars were reported to be painful or to be irritated by the overlying cloths. No limitation of the daily activities was demonstrated and in fact, all patients described a considerable improvement over the preoperative state. Many patients had become active in various athletic activities without any restriction. DISCUSSION The key-point of the success of the surgical approaches and the patients’ satisfaction relates to the recognition of the unique characteristics of the patient population with H.S. disease. Patients with chronic H.S. have generally suffered with their disease for many years before any surgical intervention [3,17]. They are quite familiar with the dressing techniques and therefore require little reinforcement to maintain themselves during the prolonged interval of healing. Their pain threshold has been, through 235 the chronicity of the discomfort, heightened to a point where they tolerate the open wound technique with very minimal need for analgesia. Their entire lifestyle has for so long focussed about showers, baths and dressing changes. The present study agrees with the previous investigation that appreciates a definite sense of well being attributed to early mobilization of the patient [6]. We have recognized an extreme patient satisfaction attributed to their selfparticipation in their wound care. From these key points and before decision-making was taken, many aspects must be considered. This includes; first: the region affected, second: to start with conservative treatment or to excise the affected skin, third: to use either surgical or laser-assisted excision, fourth: to cover or to leave the defect for granulation and finally: what type of coverage if it was decided. Initiative conservative measures could be started with [3], however, in the present study, we preferred to start with local excision taking into consideration the long time spent before requesting the surgical advice especially when the history of recurrence was present. Moreover, CO2 laser assisted excision was applied in few selected cases at the present study. It could offer a rapid, efficient and economical technique, which could be applied alone as a simple treatment modality in some early lesions [19-21] . Moreover, CO2 laser excision could give a hand for better diagnosis of coagulase negative staphylococci at the deeper planes of H.S. diseased area for selective postoperative antibiotic coverage [22]. Excision and debridement of the affected skin and apocrine glands were applied in the present study as the only line of treatment for H.S. disease affecting the perianal and perineal regions when healing with secondary intention is the end point of the treatment. This is true as anal stenosis could be complicating after splitthickness skin graft covering [7,8] and the concepts for diverting colostomy became obsolete especially after the introduction of well-planned bowel protocols [9]. This modality of treatment has different advantages namely; easier postoperative care, full and early ambulation, no donor sites, no losses of skin grafts, short-term hospitalization and early return to work [11]. In H.S. disease of the gluteal region, on the contrary, the split-thickness graft could be considered the 236 preferred line of treatment especially with the introduction of the recycled skin grafting from the resected skin without the need for a donor area [2]. The true dilemma of the proper line of treatment was for the coverage of the defects after excision of H.S. disease at the groin and the axillae. In H.S. disease at the groin, some authors suggested to keep the defect opened for secondary intention [11] while others preferred closure by flap coverage [10]. In the present study, we preferred coverage for cases with H.S. disease at the groin by flaps. It could offer earlier mobilization, lesser hospitalization, lesser dependency for dressings and better healing for patients’ satisfaction. In H.S. disease at the axilla, we preferred to cover the defects by both splitthickness grafts and flaps taking into consideration the size of the defect as the previous studies did not decide the ideal way for covering of those defects with different reported recurrence rates [1,13,16,18]. In the present study, the only case with recurrence was at the axilla, precisely at the margin of the excised skin. This could be attributed to a defect of the proper wide excision of the affected skin and apocrine glands rather than a defect of the covering technique, especially, when the recurrence was for the second time. At an earlier stage of the present study, we were not appreciated the patients’ characteristics and premature impatience with the slow healing. So, prompted reappraisal of our treatment program to selectively offer skin grafting to several patients to expedite healing was done. The present study stresses about the idea of the potential source of dissatisfaction for those patients regardless of the treatment modality. In as much as it hardly seems advisable to extend the operative resection beyond the actively diseased apocrine tissue, the potential for further disease in the previously uninvolved areas is quite real. Patients need to be clearly informed of this possibility so as not consider the original operation a failure. The small percentage at the present study with such a problem represents the severity of the disease on the initial presentation and the fact that nearly complete apocrine gland excision occurred with excision of all active diseased skin. Conclusion: H.S. disease is a chronic long-lasting prob- Vol. 27, No. 2 / Hidradenitis Suppurativa lem. The debate about its ideal line of treatment is a superimposed problem, taking into consideration the affected regions. Simple wide excision could be attributed as the universal line of treatment alone or in conjunction with different ways to cover the defects. The optimum goal of treatment is to control the disease with good functional and cosmetically acceptable properties, as well as, the least incidence of disease recurrence. Patients’ satisfaction is directly attributed to the previous goals and in addition to the early ambulation, early discharge, home-based wound care until healing is complete to minimize the operative and hospitalization costs in a time of escalating the medical expenditures and the potential governmental intervention. REFERENCES 1- Geh J.L. and Niranjan N.S.: Perforator-based fasciocutaneous island flaps for the reconstruction of axillary defects following excision of hidradenitis suppurativa. Br. J. Plast. Surg., 55 (2): 124-128, 2002. 2- Kuo H.W. and Ohara K.: Surgical treatment of chronic gluteal hidradenitis suppurativa: reused skin graft technique. Dermatol. Surg., 29 (2): 173-178, 2003. 3- Mitchell K.M. and Beck D.E.: Hidradenitis suppurativa. Surg. Clin. North Am., 82 (6): 1187-1197, 2002. 4- Manolitsas T., Blankin S., Jaworski R. and Wain G.: Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Gynecol. Oncol., 75 (2): 285288, 1999. 5- Elwood E.T. and Bolitho D.G.: Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann. Plast. Surg., 46 (1): 49-51, 2001. 6- Tanaka A., Hatoko M., Tada H., Kuwahara M., Mashiba K. and Yurugi S.: Experience with surgical treatment of hidraenitis suppurativa. Ann. Plast. Surg., 47 (6): 636-642, 2001. 7- Ramasastry S.S., Conklin W.T., Granick M.S. and Futrell J.W.: Surgical management of massive perianal hidradenitis suppurativa. Ann. Plast. Surg., 15 (3): 218-223, 1985. 8- Rubin R.J. and Chinn B.T.: Perianal hidradenitis suppurativa. Surg. Clin. North Am., 74 (6): 1317-1325, 1994. 9- Tofield J.J.: Intravenous hyperalimentation: A valuable aid for perianal skin grafting. Br. J. Plast. Surg., 30: 154-158, 1977. 10- Billet A., Stueber K. and Vaughan L.: Hidradenitis suppurativa of unusual severity. Ann. Plast. Surg., 10: 231-236, 1983. 11- Ariyan S. and Krizek T.J.: Hidradenitis suppurativa of the groin, treated by excision and spontaneous healing. Plast. Reconstr. Surg., 58 (1): 44-47, 1976. Egypt, J. Plast. Reconstr. Surg., July 2003 12- Elliot D., Kangesu L., Bainbridge C., Venkataramakrishnan V.: Reconstruction of the axilla with a posterior arm fasciocutaneous flap. Br. J. Plast. Surg., 45 (2): 101-104, 1992. 13- Soldin M.G., Tulley P., Kaplan H., Hudson D.A. and Grobbelaar A.O.: Chronic axillary hidradenitis: the efficacy of wide excision and flap coverage. Br. J. Plast. Surg., 53 (5): 434-436, 2000. 14- Schwabegger A.H., Herczeg E. and Piza H.: The lateral thoracic fasiocutaneous island flap for the treatment of recurrent hidradenitis axillaris suppurativa and other axillary skin defects. Br. J. Plast. Surg., 53 (8): 676678, 2000. 15- Amarante J., Reis J., Santa Comba A. and Malheiro E.: A new approach in axillary hidradenitis treatment: the scapular island flap. Aesthetic Plast. Surg., 20 (5): 443-446, 1996. 16- Morgan W.P., Harding K.G. and Hughes L.E.: A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa. Ann. R. Coll Surg. Engl., 65 (4): 235-236, 1983. 17- Watson J.D.: Hidradenitis suppurativa: a clinical review. 237 Br. J. Plast. Surg., 38 (4): 567-569, 1985. 18- Hynes P.J., Earley M.J. and Lawlor D.: Split-thickness skin grafts and negative-pressure dressings in the treatment of axillary hidradenitis suppurativa. Br. J. Plast. Surg., 55 (6): 507-509, 2002. 19- Lapins J., Marcusson J.A. and Emtestam L.: Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique. Br. J. Dermatol., 131 (4): 551-556, 1994. 20- Finley E.M. and Ratz J.L.: Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing. J. Am. Acad. Dermatol., 34 (3): 465-469, 1996. 21- Lapins J., Sartorius K. and Emtestam L.: Scannerassisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J. Am. Acad. Dermatol., 47 (2): 280-285, 2002. 22- Lapins J., Jarstrand C. and Emtestam L.: Coagulasenegative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br. J. Dermatol., 140 (1): 90-95, 1999.